Quarterly report pursuant to Section 13 or 15(d)

Segment Information

v3.22.4
Segment Information
3 Months Ended
Nov. 30, 2022
Segment Information  
Segment Information

18. Segment Information

 

The Company’s operations involve the development and usage, including licensing, of its proprietary DehydraTECH Technology. Lexaria is centrally managed and its chief operating decision makers, being the president and the CEO, use the consolidated and other financial information supplemented by revenue information by category of alternative health consumer products and technology licensing to make operational decisions and to assess the performance of the Company. The Company has identified two reportable segments: Intellectual Property and Products. Licensing revenues are significantly concentrated on one licensee.

Three Months Ended

November 30, 2022

 

IP Licensing

$

 

 

B2B

$

 

 

Corporate

$

 

 

Consolidated Total

$

 

Revenue

 

 

63,435

 

 

 

29,100

 

 

 

8,941

 

 

 

101,476

 

Cost of goods sold

 

 

-

 

 

 

(15,795 )

 

 

-

 

 

 

(15,795 )

Operating expenses

 

 

(707,034 )

 

 

(10,992 )

 

 

(1,136,961 )

 

 

(1,854,987 )

Segment income (loss)

 

 

(643,599 )

 

 

2,313

 

 

 

(1,128,020 )

 

 

(1,769,306 )

Total assets

 

 

118,096

 

 

 

75,723

 

 

 

6,019,661

 

 

 

6,213,480

 

 

Three Months Ended

November 30, 2021

 

IP Licensing

$

 

 

Products

$

 

 

Corporate

$

 

 

Consolidated Total

$

 

External revenue

 

 

-

 

 

 

7,000

 

 

 

6,880

 

 

 

13,880

 

Cost of goods sold

 

 

-

 

 

 

(5,570 )

 

 

-

 

 

 

(5,570

Operating expenses

 

 

(837,750 )

 

 

(77,002 )

 

 

(1,097,040 )

 

 

(2,011,792 )

Segment loss

 

 

(837,750 )

 

 

(75,572 )

 

 

(1,090,160 )

 

 

(2,003,482 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total assets

 

 

724,665

 

 

 

116,060

 

 

 

10,905,217

 

 

 

11,745,942

 

 

Capital Asset by Region

 

Cost

US

 

 

Addition

US

 

 

Net Balance

US

 

 

Cost

Canada

 

 

Net Balance Canada

 

 

Total Net Balance

 

Three Months Ended

November 30, 2022

 

$

 

 

$

 

 

$

 

 

$

 

 

$

 

 

$

 

Leasehold Improvements

 

 

-

 

 

 

-

 

 

 

-

 

 

 

259,981

 

 

 

51,786

 

 

 

51,786

 

Computers

 

 

-

 

 

 

-

 

 

 

-

 

 

 

70,781

 

 

 

8,174

 

 

 

8,174

 

Furniture & Fixtures

 

 

-

 

 

 

-

 

 

 

-

 

 

 

31,126

 

 

 

6,684

 

 

 

6,684

 

Lab Equipment

 

 

140,487

 

 

 

20,500

 

 

 

116,553

 

 

 

193,185

 

 

 

128,024

 

 

 

244,577

 

 

 

 

140,487

 

 

 

20,500

 

 

 

116,553

 

 

 

555,073

 

 

 

194,668

 

 

 

311,221

 

 

Capital Asset by Region

 

Cost

US

 

 

Addition

US

 

 

Net Balance

US

 

 

Cost

Canada

 

 

Addition Canada

 

 

Net Balance Canada

 

 

Total Net Balance

 

Year Ended August 31, 2022

 

 $

 

 

 $

 

 

 $

 

 

$

 

 

 

 

$

 

 

$ 

 

Leasehold Improvements

 

 

-

 

 

 

-

 

 

 

-

 

 

 

259,981

 

 

 

-

 

 

 

65,296

 

 

 

65,296

 

Computers

 

 

-

 

 

 

-

 

 

 

-

 

 

 

63,964

 

 

 

6,817

 

 

 

9,357

 

 

 

9,357

 

Furniture & Fixtures

 

 

-

 

 

 

-

 

 

 

-

 

 

 

31,126

 

 

 

-

 

 

 

8,288

 

 

 

8,288

 

Lab Equipment

 

 

98,050

 

 

 

42,375

 

 

 

100,031

 

 

 

193,185

 

 

 

-

 

 

 

132,533

 

 

 

232,564

 

 

 

 

98,050

 

 

 

42,375

 

 

 

100,031

 

 

 

548,256

 

 

 

6,817

 

 

 

215,474

 

 

 

315,505